Ralliant RAL

Current Stats

Post-Spinoff Performance

Computed from split-adjusted closing prices. Returns are total return — (end price + dividends received − start price) ÷ start price — with no reinvestment assumed.

Post-Spin Analysis — August 25, 2026

Written against the August 24 close of $62.95. Primary sources: the FY2025 Form 10-K (filed 2026-02-26), the Q2 2026 Form 10-Q (filed 2026-07-30), and the Form 10 information statement, which carries segment financials back to 2022. Four years of segment history plus three quarters of standalone reporting — the deepest record of any recent name we cover.

The one-line version

Ralliant is two businesses stapled together, and only one of them is working.

Sensors and Safety Systems — power-grid monitoring, aerospace and defense ignition systems, precision sensing — earns 28.4% operating margins and grew 11.5% last quarter. Test and Measurement — Tektronix oscilloscopes and the Elektro-Automatik high-power business — earns 2.4% and took a $1.44 billion goodwill impairment in 2025 on collapsing EV-related demand.

The stock is +30.2% since the June 2025 spin and has beaten the S&P by 12.3 percentage points annualised. That is the problem. At $62.95 it trades at 17.5x EV/EBITDA and 30.9x earnings.

Four years of segment history from the Form 10 confirm it. Sensors is extraordinary but barely grows — a 1.3-point margin band across four years on +1.3% revenue CAGR. Test & Measurement is more cyclical than one year showed, with a 20.3% peak margin in 2023 against 2.4% today. Put both at their best — Sensors at a generous 17x EBIT and Test & Measurement back at its 2023 peak — and the sum of the parts reaches exactly $63, which is where the shares trade. Everything good that could plausibly happen is already in the price.

Rating HOLD. Target $58. Grade A− (3.50). A genuinely good business inside a fully-priced stock, with the recovery already in the number.

What the business actually is

Fortive’s Precision Technologies segment, separated on June 30, 2025. Two segments that share almost nothing beyond a former parent:

Read the margin column. Sensors is 61% of sales and produces roughly all of the operating profit. Test & Measurement contributes 39% of revenue and, currently, almost nothing.

Sensors is the better business by a distance, and its end markets are the ones capital is flowing toward: grid monitoring sits inside the electrical infrastructure build-out, and the energetics business sells into satellite deployment and defense. Those are not cyclical consumer markets.

Management Team

The board is the interesting part. Ganesh Moorthy ran Microchip through a full semiconductor cycle, and Test & Measurement’s problem is precisely a semiconductor and electronics demand cycle. Two founding Fortive directors carrying over means the Fortive Business System — the operating discipline inherited from Danaher — has continuity at board level.

Capital allocation has been decisive, which is the strongest early evidence about this management team. See below.

The financial record — four years by segment

The Form 10 carries segment financials back to 2022. They change two of the inputs this analysis rests on, and they confirm the conclusion.

Sensors and Safety Systems is an annuity

A 1.3-percentage-point margin band across four years including a recession-like 2025. That is genuinely exceptional stability, and it is the strongest single fact about this company.

But look at the revenue column. Four-year CAGR of +1.3% — this business was flat until 2025. Q2’s 28.4% margin is at the top of its historical range, not a new level. A 27%-margin business growing 1% is not an 18x-EBIT business, which is a correction to the first version of this analysis.

The genuine news is 1H 2026’s +11.0%. If grid and defense spending has inflected Sensors from a 1% grower to a high-single-digit one, that changes the multiple it deserves. Two quarters is not enough to say.

Test and Measurement is far more cyclical than one year showed

FY2025 shown excluding the $1.44B goodwill impairment.

The peak margin was 20.3% in 2023, not the 13.1% used in the first version of this analysis. That makes the recovery case materially larger than modeled — the correction runs in the stock’s favor.

The trap in comparing 2026 with the carve-out years

FY2024’s two segments sum to $459.6M, which is exactly the reported total. There is no unallocated corporate line, because the carve-out never carried standalone public-company costs. Ralliant now runs roughly $87M a year of them.

So the raw comparison — 21.3% in 2024 against 14.5% in Q2 2026 — is not like-for-like. Restating history on a standalone basis:

The gap back to the pre-collapse level is about 3 points, not 7. That is a more achievable recovery than the headline numbers imply — and it is the same class of error as valuing a spinoff off carve-out earnings that carry no interest expense. The carve-out flattered the past twice: no interest, and no corporate overhead.

What the longer record settles

Revenue has been flat for four years — $2,089.7M in 2022 against $2,068.8M in 2025, a −0.3% CAGR. The 2025 decline was not a break in trend so much as a cyclical low in a business that has not grown. 1H 2026’s +11.9% is a recovery off that low.

The company is Sensors plus an option. Sensors delivered between $320M and $341M of operating profit in every one of the four years, including 2025. Test & Measurement delivered $142M, $191M, $123M and negative $25M. All of the volatility, and none of the reliability, sits in the smaller segment.

Where Ralliant sits in the value chain

The competitive section below names the competitors. This one asks a different question — who sets the price — and the answer explains the margin column better than anything else on this page.

One principle runs through the good half of this company

Ralliant’s strong businesses all sell a small-cost, high-consequence part.

When the buyer’s cost of failure vastly exceeds the price of the component, the buyer does not shop on price. They qualify a supplier, design it in, and stop thinking about it. That is the entire explanation for a 28.4% segment margin in Sensors and Safety Systems, and it is a more durable arrangement than a technology lead, because it survives the technology changing.

The evidence is unusually direct

Most companies make you infer pricing power. Ralliant’s 10-K states it: the 2025 revenue decline of 4.0% was volume down 7.3%, “partially offset by favorable pricing of 3.2%.”

Read that again, because it is rare. Ralliant raised price 3.2% in a year its volumes fell 7.3%. Almost no supplier can do that. The normal response to a volume decline is to defend utilisation with price — and a business that instead holds price and lets the volume go is telling you its customers have nowhere else to go.

This is the single cleanest demonstration of pricing power available in these filings, and it is the reason the sum-of-the-parts below credits Sensors with a multiple that looks generous against a company earning 14.5% blended margins.

Test and Measurement is the exception, and it proves the principle

An oscilloscope is not a small-cost, high-consequence part. It is a capital purchase, compared specification against specification with Keysight’s, bought out of an engineering budget that can be deferred a year. The buyer has time, alternatives and a directly comparable quote.

So the power runs the other way, and the numbers follow exactly:

That last row is the one worth sitting with. Sensors carries almost no acquired intangibles; Test & Measurement carries them at fifty times the intensity. Ralliant’s strong segment was built; its weak segment was bought — and the $1.44B write-off is the market’s verdict on the difference.

What this means for the valuation

Ralliant is two businesses at opposite ends of the pricing spectrum, and the share price averages them. That is the whole opportunity and the whole risk:

• If Sensors is valued separately, its economics — annuity revenue, 27%+ margins, demonstrated pricing power, grid and defense end markets — support a multiple the blended company does not get.
• If Test & Measurement recovers, the blend improves without Sensors changing.
• If Test & Measurement does not, the market is right to average them, and a business earning 14.5% blended margins should not trade like one earning 27%.

The pricing evidence is the reason to think the first two are more likely than the third. A company that can raise price into a 7.3% volume decline has not lost its position; it is waiting for the volume.

Why the stock moved the way it did

Two enormous, opposite single-session reactions, both on earnings:

Day-1 close $48.49 · post-spin low $38.39 on 2026-02-05 — 220 sessions in, not a forced-selling flush · all-time high $73.63 on 2026-06-30 · now $62.95, 14.5% below that high and 64.0% above the low.

The low arrived 220 days after the spin, on an earnings shock. That is worth flagging because it is not the pattern the forced-selling literature predicts. Day-1 volume ran 23.7x baseline and the flush passed without setting the low; the actual bottom came seven months later on a $1.44B write-off. The mechanical seller and the price low were completely different events, separated by more than half a year.

Volume today still runs 1.19x baseline — unusually elevated for a name 14 months past separation.

Realised volatility is 48.9% annualised.

Capital allocation — the strongest evidence about management

Ralliant has been buying its own stock aggressively, and buying it well:

They repurchased roughly 2.5% of the company in six months at an average price 13% below today’s. The Q1 buying at $42.40 came within weeks of the February crash — buying into a 31.8% single-day decline on their own results is either conviction or good fortune, and either way it worked.

There is also a small dividend: $0.05 quarterly, a 0.3% yield.

Valuation

Debt structure: $1.15 billion of term loans drawn on June 27, 2025 — paid directly to Fortive as consideration for the assets contributed at separation. Refinanced in March 2026 into a $550M term loan due March 2029 and a $600M three-year facility, at slightly better spreads. Covenant is a 3.50x consolidated net leverage ratio; actual is 1.95x, so there is real headroom.

The now-familiar pattern: the spun-off business borrowed to pay its parent. It is the third recent separation we have examined where that happened, and the leverage stays on this side of the line.

Sum of the parts — where the value actually sits

The two segments are so different that the blended multiple means little. Valuing them separately, using the four-year record rather than one quarter:

Sensors annualises to $394M of EBIT. Test & Measurement earns $22M today; $116M at its 2024 margin; $180M at its 2023 peak of 20.3%. Unallocated corporate costs of $87M a year are deducted, and T&M is valued at 12x throughout.

The best case available reaches exactly today’s price. Seventeen times EBIT for a business growing 1.3% a year over four years is generous, and assuming Test & Measurement returns all the way to its 2023 peak margin is the most favorable assumption in the record. Together they get to $63, which is where the shares trade.

This is a stronger version of the conclusion the first pass reached with less data. Everything good that could plausibly happen is already in the price.

Discounted cash flow

All assumptions stated.

Base case $61 — roughly today’s price. The DCF and the sum-of-the-parts agree that the shares are close to fully valued.

Tail scenarios

Upside tails

1. Test & Measurement returns to its 2023 peak. The segment earned 20.3% in 2023 — its best year in the four-year record — against 2.4% today. Reaching it again is worth roughly $158M of incremental EBIT and about $17 a share at 12x. This is the single largest upside available and it requires no new business, only a cycle. It is also already embedded in the top row of the sum-of-the-parts above, which is why that row reaches today’s price rather than exceeding it.

2. The buyback keeps compounding. $400M remains on the authorisation, roughly 5.7% of the market capitalization. At the current pace management retires 5% of the shares a year, which adds directly to per-share value and has been executed below the current price so far.

3. Sensors’ growth inflection proves real. The four-year record shows +1.3% revenue CAGR; 1H 2026 ran +11.0%. If grid and defense spending has genuinely re-rated this business from a 1% grower to a high-single-digit one, it deserves a materially higher multiple than the 13–15x its history supports — and every turn of Sensors’ multiple is worth about $3.60 a share. This is the upside the four-year record cannot yet rule in or out, and it is the reason to watch Q3 closely.

3b. Sensors gets valued separately. A business delivering $320–341M of operating profit in every year including a recession would command a higher multiple standalone. The two segments have no operating overlap.

4. Amortization rolls off. D&A runs 5.3% of sales, heavily acquisition intangibles. As those amortise, reported earnings converge upward toward cash earnings without any operational change.

Downside tails

1. The impairment was not the end of it. The $1.44 billion write-down covered EA on reduced EV forecasts. If EV adoption forecasts fall further, the remaining Test & Measurement goodwill is exposed, and a second impairment would reset the narrative that 2026 is a clean recovery.

2. The recovery is a restocking cycle, not demand. Test & Measurement went −14.5% to +13.3% in two quarters. Instrument businesses are prone to inventory cycles at distributors. Two quarters cannot distinguish genuine end demand from a channel refill, and the multiple assumes the former.

3. Multiple compression alone. At 17.5x EV/EBITDA and 30.9x earnings, a de-rating to a normal industrial 12–13x EV/EBITDA takes the shares to $44–48 with no change in the business at all — −24% to −30%. This is the most likely downside and it requires nothing to go wrong operationally.

4. Pricing was doing the work. 2025 organic revenue was volume −7.3% and price +3.2%. If pricing normalizes while volumes stay soft, the margin recovery stalls.

Earnings-based valuation

For a mature industrial, earnings are as informative as cash flow — and on this name the reported figures need two corrections before they mean anything.

Ralliant’s carve-out years carried neither interest expense nor corporate overhead. The comparison the income statement invites is therefore misleading in both directions:

Earnings per share fell 9% while the business grew revenue 11.9% and held margin. The entire decline is the capital structure — $1.15B borrowed at separation and paid to Fortive. Nothing operational happened.

Normalized standalone earnings, at ~$56M of annual interest (Q2 ran $13.8M), a 16.5% effective tax rate and 112.6M diluted shares:

The standalone-equivalent margins deduct ~$87M a year of corporate cost the carve-out never carried. The four-year record: 18.5% (2022), 19.7% (2023), 17.3% (2024), 9.6% (2025), 14.5% (Q2 2026 annualised).

The three methods agree, which is the useful result

A full margin recovery to what this business earned before the collapse, valued at 22 times earnings, produces $59. Twenty-two times is a full multiple for a diversified industrial; the DCF and the sum-of-the-parts reach the same place by different routes.

Three independent methods converging just below the current price is a stronger result than any one of them. It is also the clearest statement of the problem: there is no assumption set inside the four-year record that justifies $62.95. Reaching it requires either a margin above anything this business has earned as a standalone company, or a multiple above what industrials command.

Price target: $58 · range $45–72 · HOLD

Method	Value
DCF — 10.5% WACC, 13x exit EV/EBITDA	$61
Sum of the parts — Sensors 17x, T&M back at its 2023 peak	$59
Earnings — full margin recovery at 22x	$59
Sum of the parts — Sensors 15x, T&M recovered	$49
De-rating to 12–13x EV/EBITDA	$44–48
T&M reaching Fortive-era margins	~$78

Base $58 is −8% to the August 24 close.

Recommendation: HOLD. This is a quality asset — the Sensors business is genuinely excellent and management has allocated capital well — trading above what the assets support. The February crash was the opportunity and it has passed: the stock has risen 64% from that low and now discounts a Test & Measurement recovery that has two quarters of evidence behind it.

What would make it a BUY. A pullback toward $48–50, which the sum of the parts supports even on conservative assumptions. Or two more quarters establishing that T&M’s recovery is end demand rather than restocking, which would justify the multiple rather than requiring it to compress.

Why not a SELL. The buyback is real and well-executed, leverage is modest at 1.95x with a 3.50x covenant, Sensors’ end markets are structurally supported, and a future separation of the two segments is a live possibility. Being 8% above fair value with those options is a hold, not an exit.

What this most resembles

Matching on structure — a diversified industrial spun from a serial separator, containing one high-margin franchise and one cyclical business — the universe offers a specific and useful set.

Four of six beat the index — a materially better hit rate than the universe’s 32.7%, and better than the auto-supplier or chemicals cohorts. Quality industrials spun from disciplined parents are one of the better categories in this data.

Vontier is the one to study, because it is the same parent

Fortive spun Vontier — fuel dispensing and vehicle repair technology — in October 2020. It is +19.4% from its day-1 price nearly six years later, which sounds acceptable until you compare it with the index: it has trailed the S&P by 11.3 percentage points annualised, with a −54.7% maximum drawdown. Rising and losing to the index is what an underperforming spinoff looks like from the inside.

Fortive has done this before, and the last one did not work. The pattern in both cases is the same: Fortive retained the businesses with the cleanest compounding characteristics and separated the ones with more cyclical or structurally challenged end markets. Vontier got fuel dispensing as electric vehicles approached; Ralliant got Test & Measurement carrying an EV-exposed acquisition that needed a $1.44B write-off within eighteen months.

That is not a prediction — Ralliant’s Sensors business is a genuinely better asset than anything inside Vontier. But when the same parent runs the same play twice, the previous outcome is evidence, and it argues against paying a premium multiple for the second one.

The counter-case is nVent, spun from Pentair in 2018: an electrical enclosures business with a niche, specified-in position that compounded 595%. Ralliant’s Sensors segment has that character — grid monitoring and defense energetics are specified into infrastructure and platforms with long lives. If Ralliant works over a decade, Sensors is why.

In depth: competitive dynamics

1. Two segments, two competitive positions

2. Moats and weak spots

✅ Energetics is the real moat. Ignition and separation devices for satellites and rockets are qualified per platform, and a failure is catastrophic — so switching is close to unthinkable once designed in. That is TransDigm-like economics in a small package, and it explains the 28.4% segment margin.

✅ Grid monitoring rides a structural spend cycle. Transmission and distribution investment is rising across every developed market, and the diagnostic layer is a small percentage of a large capital program.

⚠️ Test & Measurement is number two in a cyclical market. Tektronix competes with Keysight, which is larger and more diversified. Being second in a business whose demand swings 17% on volume is a difficult position.

❌ The EA acquisition was a bet on EV adoption timing that did not pay. The capability is real; the demand forecast was wrong.

3. The Fortive Business System question

Ralliant inherits the operating discipline Fortive inherited from Danaher — continuous improvement, disciplined pricing, bolt-on acquisition integration. The +3.2% pricing achieved in 2025 while volumes fell 7.3% is direct evidence it is functioning — and, as the value-chain section above argues, evidence of something more durable than an operating system. Whether it survives the separation from the parent that ran it is a genuine open question, and two founding Fortive directors on the board is the main reason to think it might.

In depth: valuation against peers

Ralliant is not obviously mispriced against its peer group — it is priced as a quality industrial, which the blended company is not yet. The Sensors segment would deserve the top of that range. Test & Measurement, earning 2.4% margins, would not.

The multiple therefore embeds the recovery. That is the whole valuation argument in one sentence: you are paying an “it worked” multiple for a business where two of the last six quarters showed it working.

Peer multiples are indicative ranges from industry sources rather than figures computed from primary filings, and are labeled as such.

In depth: is Ralliant an acquisition target?

Not before June 30, 2027, when the §355(e) two-year window from the Fortive separation closes. An acquisition of 50% or more inside that period would risk making the spin taxable to Fortive, with the cost falling on Ralliant under the tax matters agreement.

After that, the more interesting transaction is a break-up, not a sale.

The strategic logic points toward another separation. Fortive separated Ralliant to focus itself; the same argument applies one level down. A buyer of the shares today is partly buying the option that management reaches the same conclusion — and the fact that the board contains two founding Fortive directors, at a company built on portfolio surgery, makes that less speculative than it sounds.

What would change this view

Investment Scorecard

Scored on the five weighted dimensions set out in our methodology.

What the value-chain work changed: nothing, and the reason is worth stating

Competitive Position holds at 4.0. The pricing evidence — +3.2% price taken in a year volumes fell 7.3% — is the strongest demonstration of bargaining power in these filings, and it argues for a higher score. Against it, 39% of revenue sits in Test and Measurement, where the buyer compares specifications against Keysight’s and defers the purchase, and where a $1.44B write-off has already been taken. Half a strong business and half an impaired one averages to 4.0, which is where it was.

One structural fact was added rather than scored. Sensors carries amortization at 0.2% of sales and Test and Measurement at 10.6% — the strong segment was built and the weak one was bought. That is already charged to Strategic Rationale through the acquired-intangibles discount, and charging it again here would be double-counting a single objection.

The target is unchanged at $58. Nothing in this section touches the cash flows or the sum-of-the-parts.

First grade for this company — and grade and rating point opposite ways

A− (3.50) on quality, HOLD on price. This is the mirror image of Versigent, where a B+ business trades at 7.4x earnings; here an A− business trades at 30.9x.

The grade reflects a genuinely excellent Sensors franchise and a management team whose capital allocation has been consistently well judged. The rating reflects that a sum-of-the-parts crediting Sensors with 18x EBIT and a full Test & Measurement recovery still lands below the current price.

The grade takes effect with the next published report.

What would take it to A: Test & Measurement margin recovering into double digits, which would make the blended multiple defensible rather than demanding. What would take it down: a second impairment, or evidence that the 2026 recovery was a restocking cycle.